Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1957 1
1958 3
1959 2
1961 1
1968 1
1969 2
1970 4
1971 3
1972 1
1973 2
1974 3
1975 2
1976 4
1977 3
1978 2
1979 2
1981 3
1982 1
1983 1
1984 2
1985 1
1987 6
1988 5
1989 4
1990 4
1991 4
1992 3
1994 2
1995 3
1996 3
1997 3
1998 1
1999 1
2000 4
2001 3
2002 3
2003 4
2004 8
2005 1
2006 5
2007 5
2008 8
2009 7
2010 10
2011 7
2012 5
2013 9
2014 10
2015 14
2016 7
2017 12
2018 16
2019 17
2020 18
2021 20
2022 21
2023 24
2024 13
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Sanyal AJ, Newsome PN, Kliers I, Østergaard LH, Long MT, Kjær MS, Cali AMG, Bugianesi E, Rinella ME, Roden M, Ratziu V; ESSENCE Study Group. Sanyal AJ, et al. N Engl J Med. 2025 Jun 5;392(21):2089-2099. doi: 10.1056/NEJMoa2413258. Epub 2025 Apr 30. N Engl J Med. 2025. PMID: 40305708 Clinical Trial.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM, Korochanskaya NV, Kucheryavii UA, Lazebnik LB, Livzan MA, Maev IV, Martynov AI, Osipenko MF, Sas EI, Starodubova A, Uspensky YP, Vinnitskaya EV, Yakovenko EP, Yakovlev AA. Aghemo A, et al. Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854. Ann Med. 2022. PMID: 35635048 Free PMC article. Review.
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance.
Bujanda L, Nyssen OP, Ramos J, Bordin DS, Tepes B, Perez-Aisa A, Pavoni M, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Phull PS, Buzás GM, Machado JC, Boltin D, Boyanova L, Tonkić A, Marlicz W, Venerito M, Vologzanina L, Fadieienko GD, Fiorini G, Resina E, Muñoz R, Cano-Català A, Puig I, García-Morales N, Hernández L, Moreira L, Megraud F, Morain CO, Montes M, Gisbert JP; Hp-EuReg investigators; Hp-EuReg investigators. Bujanda L, et al. Am J Gastroenterol. 2024 Apr 1;119(4):646-654. doi: 10.14309/ajg.0000000000002600. Epub 2023 Nov 17. Am J Gastroenterol. 2024. PMID: 37983769
[Diet therapy for irritable bowel syndrome].
Bakulin IG, Avalueva EB, Оrеshkо LS, Sitkin SI, Shevyakov MA, Serkova MU, Semenova EA. Bakulin IG, et al. Ter Arkh. 2020 Sep 3;92(8):118-127. doi: 10.26442/00403660.2020.08.000759. Ter Arkh. 2020. PMID: 33346471 Review. Russian.
[Liver cirrosis and complication risk management].
Bakulin IG, Oganezova IA, Skalinskaya MI, Skazyvaeva EV. Bakulin IG, et al. Ter Arkh. 2021 Aug 15;93(8):963-968. doi: 10.26442/00403660.2021.08.200917. Ter Arkh. 2021. PMID: 36286893 Russian.
[Rehabilitation of patients with multiple sclerosis].
Korzhova IE, Bakulin IS, Poydasheva AG, Klochkov AS, Zakroyshschikova IV, Suponeva NA, Askarova LS, Zakharova MN. Korzhova IE, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(7. Vyp. 2):13-21. doi: 10.17116/jnevro202112107213. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34387441 Russian.
331 results